GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML)
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88125486
- Registration number
- 6200988
- Mark type
- Design + words
- Filed
- 20 Sept 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 17 Nov 2020
- Attorney of record
- Craig Kuchii, Esq.
Goods and services
- Class 005 — Pharmaceuticals: medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
- Class 010 — Medical apparatus: medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
Owner
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Sept 2020 — USE AMENDMENT FILED
- 13 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 24 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2020 — SOU EXTENSION 2 GRANTED
- 22 Apr 2020 — SOU EXTENSION 2 FILED
- 22 Apr 2020 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2019 — SOU EXTENSION 1 GRANTED
- 23 Oct 2019 — SOU EXTENSION 1 FILED